The real risk is not whether GenAI creates value. It will. The greater risk lies in how governments, companies, and investors respond when the market turns ...

ImmunityBio investors experienced a rollercoaster week, with the company's stock exhibiting extreme volatility against a backdrop of significant operational ach ...

Mews is advancing its ambition to power the next era of hospitality with a connected, intelligent operating system designed to unify ...

Get all latest & breaking news on Ai Summit. Watch videos, top stories and articles on Ai Summit at moneycontrol.com.

Enrollment of BCG naïve subjects (QUILT-2.005) receiving BCG alone versus BCG plus ANKTIVA exceeding expectations 85% enrolled with anticipated completion in Q2 2026 with BLA filing to U.S. Food and ...

Running used to be a cheap activity to get into it, but now expensive running gear is everywhere. The BCG Compression Tee has seen me through training for every one of my marathons. The BCG ...

We may receive a commission on purchases made from links. Roku streaming devices and smart TVs offer a dizzying amount of features and customizations. They have some hidden features every Roku user ...

Binah Capital Group Inc. (NASDAQ: BCG) surged 74.76% in after-hours trading on Thursday, rising to $2.49 after the company posted stronger-than-expected third-quarter 2025 results. The New York-based ...

Source: Getty Images BCG shortages and the fragile BCG supply chain created a bladder cancer treatment vacuum. Why? Manufacturing bottlenecks, the inherent complexity of producing a live-attenuated ...

Adding an immune checkpoint inhibitor to standard Bacillus Calmette-Guérin (BCG) therapy for non–muscle invasive bladder cancer (NMIBC) might reduce recurrences in a small fraction of patients, but ...

Boston Consulting Group is naming a new chief risk officer and putting other client-selection protocols in place after months of controversy stemming from its work on an Israeli-backed ...

Tecentriq combined with BCG did not enhance outcomes for high-risk NMIBC patients compared to BCG alone, with similar event-free survival rates. The ALBAN trial reported higher rates of side effects ...